The Centers for Disease Control and Prevention’s vaccine advisory panel postponed a vote on delaying the first dose of the hepatitis B vaccine to weigh whether the vaccine should be removed from the childhood schedule altogether, one of the advisers said on Sept. 24.
“A lot of people don’t understand what transpired there, but for me, I was faced with a decision of either voting to delay it for one month or voting against that motion and functionally endorsing administering hepatitis B vaccine at birth, continuing the standard,” Dr. Robert Malone, a member of the CDC’s Advisory Committee on Immunization Practices (ACIP), said in remarks during a call held by MAHA Action, a nonprofit that says it helps advance the Make America Healthy Again (MAHA) agenda.
